Why it was recalled
Lack of Assurance of Sterility
Product description
MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86
Lot numbers, UPCs & expiration codes
All lots within expiry
Where it was sold
Nationwide USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1682-2019
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jun 19, 2019
- FDA report date
- Aug 14, 2019
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- RXQ Compounding LLC
Original FDA data
Every field from FDA enforcement report D-1682-2019, exactly as published.
Show all FDA fields
- City
- Athens
- State
- OH
- Status
- Terminated
- Country
- United States
- Event ID
- 83074
- Address
- 340 W State St Unit 9
- Code information
- All lots within expiry
- Postal code
- 45701-1564
- Report date
- Aug 14, 2019
- Product type
- Drugs
- Recall number
- D-1682-2019
- Classification
- Class II
- Recalling firm
- RXQ Compounding LLC
- Termination date
- Sep 16, 2022
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86
- Distribution pattern
- Nationwide USA
- Recall initiation date
- Jun 19, 2019
- Initial firm notification
- Press Release
- Center classification date
- Aug 8, 2019